BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10493974)

  • 1. The v-erbA oncogene (review).
    Thormeyer D; Baniahmad A
    Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
    Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
    Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-erbA and v-erbA modulate growth and gene expression of a mouse glial precursor cell line.
    Iglesias T; Llanos S; López-Barahona M; Pérez-Aranda A; Rodríguez-Peña A; Bernal J; Höhne A; Seliger B; Muñoz A
    Cell Growth Differ; 1994 Jul; 5(7):697-704. PubMed ID: 7947384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
    Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
    EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene.
    Khazaie K; Panayotou G; Aguzzi A; Samarut J; Gazzolo L; Jurdic P
    Oncogene; 1991 Jan; 6(1):21-8. PubMed ID: 1671532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia.
    Metz T; Graf T
    Oncogene; 1992 Mar; 7(3):597-605. PubMed ID: 1347919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of expression of RA-regulated genes by the oncoprotein v-erbA.
    Ventura-Holman T; Mamoon A; Subauste JS
    Gene; 2008 Dec; 425(1-2):23-7. PubMed ID: 18775481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
    Ghysdael J; Beug H
    Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
    Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
    Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ; Maihle NJ
    Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
    Smit-McBride Z; Privalsky ML
    Oncogene; 1993 Jun; 8(6):1465-75. PubMed ID: 8099219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
    Nagl SB; Bunn CF; Allison LA
    J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
    Andersson ML; Vennström B
    Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells.
    Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A
    Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.